What do you know about Millendo Therapeutics, a drug development company?

Timeline: Millendo Therapeutics

January 5, 2016. Millendo Therapeutics sets Michigan record by raising $62 million; Ann Arbor-based company also announces partnership with drug giant AstraZeneca, Crain's Detroit Business. “I wanted a new name for the company. Atterocor was continually misspelled and mispronounced,” Millendo President and CEO Julia Owens told Crain’s on Monday. “The new name is a tribute to our past and our future.”